Abstract
The risk factors for development of paradoxical response were studied in a cohort of 104 patients with culture-documented Mycobacterium tuberculosis infection. Paradoxical deterioration occurred in 16 (15.4%) patients (case group) during antituberculosis therapy, involving lungs and pleura (n=4), spine and paraspinal tissue (n=5), intracranium (n=3), peritoneum (n=2), bone and joint (n=1), and lymph node (n=1). The median time from commencement of treatment to paradoxical deterioration was 56 days (range, 20–109 days). Compared with 53 patients without clinical deterioration after antituberculosis therapy (control group), patients with paradoxical response were more likely to have extrapulmonary involvement (62.5% vs. 17.0%; P<0.05) at initial diagnosis, to have lower baseline lymphocyte counts (672±315 cells/μl vs. 1,328±467 cells/μl; P<0.001), and to exhibit a greater surge in lymphocyte counts (627±465 cells/μl vs. 225±216 cells/μl; P<0.05) during paradoxical response. Further studies on lymphocyte subsets and cytokine levels would be useful in understanding the exact immunological mechanisms involved in immunorestitution.
Similar content being viewed by others
References
Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809
Al-Majed SA (1996) Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 90:211–214
Campbell IA, Dyson AJ (1977) Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 58:171–179
Memish ZA, Mah MW, Mahmood SA, Bannatyne RM, Khan MY (2000) Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi Arabia. Clin Microbiol Infect 6:137–141
Mofredj A, Guerin JM, Leibinger F, Masmoudi R (1996) Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient. Infection 24:390–391
Chien JW, Johnson JL (1998) Paradoxical reactions in HIV and pulmonary TB. Chest 114:933–936
Narita M, Ashkin D, Hollender ES, Pitchenik AE (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158:157–161
Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193–197
John M, French MA (1998) Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust 1998 169:473–474
Furrer H, Malinverni R (1999) Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis. Am J Med 106:371–372
Ramdas K, Minamoto GY (1994) Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDS. Clin Infect Dis 19:793–794
Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008–1009
Eyer-Silva WA, Pinto JF, Arabe J, Morais-De-Sa CA (2002) Paradoxical reaction to the treatment of tuberculosis uncovering previously silent meningeal disease. Rev Soc Bras Med Trop 35:59–61
Orlovic D, Smego RA Jr (2001) Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis 5:370–375
Navas E, Martin-Davila P, Moreno L, Pintado V, Casado JL, Fortun J, Perez-Elias MJ, Gomez-Mampaso E, Moreno S (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 162:97–99
Ramos A, Asensio A, Perales I, Montero MC, Martin T (2003) Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 22:374–376
Cheng VC, Woo PC, Lau SK, Cheung CH, Yung RW, Yam LY, Yuen KY (2003) Peripartum tuberculosis: a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 22:313–317
Valdez LM, Schwab P, Okhuysen PC, Rakita RM (1997) Paradoxical subcutaneous tuberculous abscess. Clin Infect Dis 24:734
Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892
Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL, Lee R, Chan RM (2001) Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402–406
Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC (2001) Global trends in resistance to antituberculosis drugs. N Engl J Med 344:1294–1303
Kam KM, Yip CW, Tse LW, Leung OC, Sin LP, Chan MY, Wong WS (2002) Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989–1999. Clin Infect Dis 34:324–329
Ohno H, Koga H, Kuroita T, Tomono K, Ogawa K, Yanagihara K, Yamamoto Y, Miyamoto J, Tashiro T, Kohno S (1997) Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med 155:2057–2063
Torres MJ, Criado A, Palomares JC, Aznar J (2000) Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 38:3194–3199
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, V.C.C., Yam, W.C., Woo, P.C.Y. et al. Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients. Eur J Clin Microbiol Infect Dis 22, 597–602 (2003). https://doi.org/10.1007/s10096-003-0998-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-0998-z